SFO
CVS icon

Stokes Family Office’s CVS Health CVS Stock Holding History

Stokes Family Office’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,501
Closed -$244K – 246
2023
Q3 		$244K Sell
3,501
-47
-1% -$3.33K 0.03% 273
2023
Q2 		$245K Buy
3,548
+157
+5% +$11.2K 0.03% 268
2023
Q1 		$252K Sell
3,391
-387
-10% -$32.5K 0.03% 250
2022
Q4 		$352K Sell
3,778
-450
-11% -$43.4K 0.05% 199
2022
Q3 		$403K Buy
4,228
+516
+14% +$51.1K 0.06% 177
2022
Q2 		$344K Sell
3,712
-170
-4% -$16.6K 0.05% 195
2022
Q1 		$393K Buy
3,882
+303
+8% +$31.8K 0.05% 181
2021
Q4 		$369K Buy
3,579
+206
+6% +$19K 0.05% 169
2021
Q3 		$286K Buy
3,373
+80
+2% +$6.7K 0.04% 189
2021
Q2 		$275K Buy
3,293
+102
+3% +$8.35K 0.04% 183
2021
Q1 		$241K Sell
3,191
-1,133
-26% -$82.5K 0.04% 179
2020
Q4 		$295K Buy
+4,324
New +$281K 0.06% 137
2020
Q2 		– Sell
-3,506
Closed -$208K – 130
2020
Q1 		$208K Buy
3,506
+61
+2% +$4.07K 0.06% 113
2019
Q4 		$250K Buy
+3,445
New +$242K 0.06% 113

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Stokes Family Office's CVS Position: Q4 2023 in Review

Stokes Family Office sold out of CVS Health (CVS) in Q4 2023, closing a stake of 3,501 shares — an estimated $244K sold.

Stokes Family Office first reported a position in CVS in Q4 2019 and held it in 14 quarters. The position peaked at $403K in Q3 2022. 2,257 funds tracked by Wall St. Rank hold CVS as of Q4 2023.

  • Stokes Family Office reported no remaining CVS Health position as of Q4 2023 after selling out during the quarter.
  • Stokes Family Office sold 3,501 CVS Health shares in Q4 2023, an estimated $244K.
  • Stokes Family Office first reported a position in CVS Health in Q4 2019 and held it in 14 quarters.
  • Stokes Family Office's CVS Health position peaked at $403K in Q3 2022.
  • 2,257 funds tracked by Wall St. Rank held CVS Health as of Q4 2023.

Based on Stokes Family Office's 13F filing for Q4 2023, filed 6 Feb 2024.